Regeneron Pharmaceuticals, Inc. is an American biotechnology co... - dofaq.co
Regeneron Pharmaceuticals, Inc. is an American biotechnology co...
wikipedia - 09 Oct 2020
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York, according to the company's website. The company was founded in 1988.[4] Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.
Regeneron Pharmaceuticals Inc. (REGN) Rises 3.08% for January 19
Equities.com - 19 Jan 2021
Regeneron Pharmaceuticals Inc. (REGN) Rises 3.08% for January 19 ...
Should You Rely On Regeneron Pharmaceuticals's (NASDAQ:REGN) Earnings Growth?
Simply Wall St - 18 Jan 2021
Should You Rely On Regeneron Pharmaceuticals's (NASDAQ:REGN) Earnings Growth? ...
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
The Motley Fool - 14 Jan 2021
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock? ...
Regeneron Inks Deal to Sell Covid-19 Treatment to U.S., Even as Usage Lags
Barron's - 13 Jan 2021
Regeneron Inks Deal to Sell Covid-19 Treatment to U.S., Even as Usage Lags ...
Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B
FiercePharma - 14 Jan 2021
Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B ...
$8.22 Earnings Per Share Expected for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) This Quarter
MarketBeat - 18 Jan 2021
$8.22 Earnings Per Share Expected for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) This Quarter ...
Regeneron Pharmaceuticals Inc. (REGN) Rises 3.64% for January 08
Equities.com - 08 Jan 2021
Regeneron Pharmaceuticals Inc. (REGN) Rises 3.64% for January 08 ...
Regeneron Pharmaceuticals Awarded Billions from US Army for COVID-19 Research
ClearanceJobs - 13 Jan 2021
Regeneron Pharmaceuticals Awarded Billions from US Army for COVID-19 Research ...
Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
PRNewswire - 29 Dec 2020
Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen ...
Regeneron Pharmaceuticals reports Q4 and FY20 net product sales
Seeking Alpha - 11 Jan 2021
Regeneron Pharmaceuticals reports Q4 and FY20 net product sales ...
Regeneron Pharmaceuticals Inc. (REGN) Rises 1.22% for January 13
Equities.com - 13 Jan 2021
Regeneron Pharmaceuticals Inc. (REGN) Rises 1.22% for January 13 ...
Does Regeneron Pharmaceuticals (NASDAQ:REGN) Deserve A Spot On Your Watchlist?
Simply Wall St - 04 Jan 2021
Does Regeneron Pharmaceuticals (NASDAQ:REGN) Deserve A Spot On Your Watchlist? ...
Regeneron Upgraded to Buy at Citi on Eczema Drug Potential
TheStreet - 08 Jan 2021
Regeneron Upgraded to Buy at Citi on Eczema Drug Potential ...
Regeneron's quest for a COVID-19 antibody drug
The Japan Times - 22 Dec 2020
Regeneron's quest for a COVID-19 antibody drug ...
Regeneron Pharmaceuticals, Inc. 8-K Jan. 11, 2021 6:03 AM
Seeking Alpha - 11 Jan 2021
Regeneron Pharmaceuticals, Inc. 8-K Jan. 11, 2021 6:03 AM ...
Regeneron Pharmaceuticals (NASDAQ:REGN) Has A Rock Solid Balance Sheet
Simply Wall St - 21 Dec 2020
Regeneron Pharmaceuticals (NASDAQ:REGN) Has A Rock Solid Balance Sheet ...
REGENERON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form 8-K)
marketscreener.com - 15 Jan 2021
REGENERON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form 8-K) ...
Regeneron Pharmaceuticals Inc (REGN) Stock: What Does the Chart Say?
InvestorsObserver - 12 Jan 2021
Regeneron Pharmaceuticals Inc (REGN) Stock: What Does the Chart Say? ...
Regeneron (REGN) Upgrade Lifts Range-Bound Biotech Stocks
Investopedia - 11 Jan 2021
Regeneron (REGN) Upgrade Lifts Range-Bound Biotech Stocks ...